A “very large majority” of patients with a minor form of the Covid-19 develops antibodies which could then immunize “for several weeks” against the disease, according to a study from the Pasteur Institute and the CHU of Strasbourg.
These results are “encouraging,” to the extent that little is known about the mechanisms of immunity against the novel coronavirus, especially among people with mild forms of the disease.
